TY - JOUR T1 - An interlaboratory quality control programme for the measurement of tuberculosis drugs JF - European Respiratory Journal JO - Eur Respir J SP - 268 LP - 271 DO - 10.1183/09031936.00177014 VL - 46 IS - 1 AU - Rob E. Aarnoutse AU - Marieke G.G. Sturkenboom AU - Karen Robijns AU - Anneke R. Harteveld AU - Ben Greijdanus AU - Donald R.A. Uges AU - Daniel J. Touw AU - Jan-Willem Alffenaar Y1 - 2015/07/01 UR - http://erj.ersjournals.com/content/46/1/268.abstract N2 - Tuberculosis (TB) remains a major global health problem. Inadequate exposure to TB drugs constitutes one of the main factors underlying suboptimal treatment response and development of resistance, as evidenced by results from: the in vitro hollow fibre model [1]; clinical studies on relationships between drug concentrations and response [2–5]; a pharmacogenetic trial [6]; and a recent meta-analysis [7].Quality control in TB drug measurement is essential for the development of new drugs and for patient care http://ow.ly/KxWNc ER -